thyssenkrupp nucera AG & Co. KGaA Stocks

8.26Last Updated 02.04.2026

Issuer Rating

4/7
Performance

Modest

Risk

Limited

Recommendation

Hold

Market Cap

€ 1.20B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
News
8.26
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

thyssenkrupp nucera AG & Co. KGaA designs, develops, procures, and licenses electrolysis technologies and plants in Germany, Italy, Japan, China, and internationally. The company offers engineering, procurement, commissioning, and aftermarket services for electrolysis plants. Its alkaline water electrolysis technology transforms renewable energy and water into green hydrogen for industrial use and its subsequent downstream applications, including clean and sustainable gases, fuels, chemicals, steel, and feedstocks. The company was formerly known as thyssenkrupp Uhde Chlorine Engineers GmbH. The company was founded in 1960 and is headquartered in Dortmund, Germany. thyssenkrupp nucera AG & Co. KGaA operates as a subsidiary of thyssenkrupp Projekt 1 GmbH.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of NCH2.DE is 10 and suggests 25% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks